110 related articles for article (PubMed ID: 24363240)
1. Effects of oligoelements Se, Zn, and Mn plus Lachesis muta venom in experimental scleroderma.
Crescenti EJ; Medina VA; Sambuco LA; Cremaschi GA; Genaro AM; Cricco GP; Martín GA; Valli E; Martinel Lamas DJ; Perazzo JC; Rivera ES; Bergoc RM
Biol Trace Elem Res; 2014 Feb; 157(2):138-46. PubMed ID: 24363240
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
[TBL] [Abstract][Full Text] [Related]
3. Radioprotection of sensitive rat tissues by oligoelements Se, Zn, Mn plus Lachesis muta venom.
Crescenti EJ; Medina VA; Croci M; Sambuco LA; Prestifilippo JP; Elverdin JC; Bergoc RM; Rivera ES
J Radiat Res; 2011; 52(5):557-67. PubMed ID: 21952314
[TBL] [Abstract][Full Text] [Related]
4. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
[TBL] [Abstract][Full Text] [Related]
5. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
[TBL] [Abstract][Full Text] [Related]
6. The Protective Effects of Bevacizumab in Bleomycin-Induced Experimental Scleroderma.
Koca SS; Ozgen M; Dagli AF; Gozel N; Ozercan IH; Isik A
Adv Clin Exp Med; 2016; 25(2):249-53. PubMed ID: 27627557
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.
Zhou CF; Yu JF; Zhang JX; Jiang T; Xu SH; Yu QY; Zhu QX
Clin Exp Dermatol; 2013 Jun; 38(4):403-9. PubMed ID: 23517443
[TBL] [Abstract][Full Text] [Related]
8. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
[TBL] [Abstract][Full Text] [Related]
9. Radioprotective potential of a novel therapeutic formulation of oligoelements Se, Zn, Mn plus Lachesis muta venom.
Crescenti E; Croci M; Medina V; Sambuco L; Bergoc R; Rivera E
J Radiat Res; 2009 Nov; 50(6):537-44. PubMed ID: 19823008
[TBL] [Abstract][Full Text] [Related]
10. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
[TBL] [Abstract][Full Text] [Related]
11. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
Nakamura-Wakatsuki T; Oyama N; Yamamoto T
Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma.
Ozgen M; Koca SS; Dagli AF; Gundogdu B; Ustundag B; Isik A
Clin Exp Dermatol; 2012 Jan; 37(1):48-54. PubMed ID: 22182434
[TBL] [Abstract][Full Text] [Related]
13. Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains.
Yamamoto T; Kuroda M; Nishioka K
Arch Dermatol Res; 2000 Nov; 292(11):535-41. PubMed ID: 11194891
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin prevents the development of dermal fibrosis in bleomycin-induced scleroderma.
Koca SS; Ozgen M; Sarikaya M; Dagli F; Ustundag B; Isik A
Clin Exp Dermatol; 2014 Mar; 39(2):176-81. PubMed ID: 24033834
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of etanercept in bleomycin-induced experimental scleroderma.
Koca SS; Isik A; Ozercan IH; Ustundag B; Evren B; Metin K
Rheumatology (Oxford); 2008 Feb; 47(2):172-5. PubMed ID: 18174229
[TBL] [Abstract][Full Text] [Related]
16. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
17. Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cells.
Ishikawa H; Takeda K; Okamoto A; Matsuo S; Isobe K
J Invest Dermatol; 2009 Jul; 129(7):1688-95. PubMed ID: 19158840
[TBL] [Abstract][Full Text] [Related]
18. Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma.
Kitaba S; Murota H; Terao M; Azukizawa H; Terabe F; Shima Y; Fujimoto M; Tanaka T; Naka T; Kishimoto T; Katayama I
Am J Pathol; 2012 Jan; 180(1):165-76. PubMed ID: 22062222
[TBL] [Abstract][Full Text] [Related]
19. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory oedema induced by Lachesis muta muta (Surucucu) venom and LmTX-I in the rat paw and dorsal skin.
Ferreira T; Camargo EA; Ribela MT; Damico DC; Marangoni S; Antunes E; De Nucci G; Landucci EC
Toxicon; 2009 Jan; 53(1):69-77. PubMed ID: 18996140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]